This article has been updated with a comment from one of the researchers.
NEW YORK – In a pair of papers published in Nature Neuroscience on Monday, teams led by researchers at the Broad Institute and Harvard Medical School found that mosaic enhancer mutations may contribute to an individual's risk of developing autism spectrum disorder (ASD), and specifically that mosaic copy number variants (mCNVs) contribute a previously unexplained component of ASD risk.